Interestingly, three criteria (the lack of mineralocorticoid receptor antagonists and SGLT-2 inhibitors in heart failure, as well as the lack of osmotic laxatives for chronic constipation) accounted for 90.3% of additional omissions identified by the new version of the START criteria. The gene discussed is SLC5A2; the disease is heart failure.